Pegylated interferon alpha associated with HBsAg clearance in postpartum women with chronic HBV infection.
New treatment clears hepatitis B in 3 out of 10 women after childbirth
This prospective cohort study evaluated 263 postpartum women with chronic hepatitis B virus infection and baseline HBsAg levels ≤3000 IU/mL.…
A new treatment clears hepatitis B markers in nearly 30% of women after childbirth, offering fresh hope for a functional cure during a uniqu…
Peg-IFN-alpha treatment in HBeAg-negative chronic hepatitis B yields virological and serological responses.
New Blood Test Predicts Hep B Drug Success
This prospective cohort study evaluated HBeAg-negative chronic hepatitis B patients treated with pegylated interferon alpha over 48 weeks. V…
A new blood test checks specific genes to predict if hepatitis B patients will respond to treatment before wasting months on ineffective med…